# Cumulative Skin Irritation Potential of a New 15 mg Nicotine Patch

> **NCT00965913** · PHASE1 · COMPLETED · sponsor: **McNeil AB** · enrollment: 42 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Nicotine Patch
- **DRUG:** Nicotine Patch Comparator
- **DRUG:** Placebo Patch

## Key facts

- **NCT ID:** NCT00965913
- **Lead sponsor:** McNeil AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2005-05
- **Final completion:** 2005-06
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2012-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00965913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00965913, "Cumulative Skin Irritation Potential of a New 15 mg Nicotine Patch". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00965913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*